Dr. Ferdinandos Skoulidis

Claim this profile
Studies Lung Cancer
1 reported clinical trial
4 drugs studied

Area of expertise

1Lung Cancer
Ferdinandos Skoulidis has run 1 trial for Lung Cancer. Some of their research focus areas include:
Stage III
Stage II
Stage I

Clinical Trials Ferdinandos Skoulidis is currently running

Image of trial facility.

Sotorasib + Chemotherapy

for Lung Cancer

This is a phase II, single-arm, open-label study evaluating the efficacy, safety and tolerability of neoadjuvant sotorasib in combination with cisplatin (or carboplatin) and pemetrexed chemotherapy for patients with surgically resectable stage IIA - IIIB (T3-T4/N2) (based on AJCC 8th edition), non-squamous NSCLC with a KRAS p.G12C mutation. The primary objective of the study is to determine whether neoadjuvant therapy with 4 cycles of at least one dose of sotorasib plus cisplatin (or carboplatin) and pemetrexed can be administered safely and result in improved MPR rate in patients with KRAS p.G12C-mutant non-squamous NSCLC compared with the historical control MPR rate for platinum-based chemotherapy alone.
Recruiting1 award Phase 215 criteria

More about Ferdinandos Skoulidis

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Ferdinandos Skoulidis has experience with
  • Carboplatin
  • Cisplatin
  • Pemetrexed
  • Sotorasib
Breakdown of trials Ferdinandos Skoulidis has run
Lung Cancer

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ferdinandos Skoulidis specialize in?
Ferdinandos Skoulidis focuses on Lung Cancer and other conditions. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Ferdinandos Skoulidis currently recruiting for clinical trials?
Yes, Ferdinandos Skoulidis is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Ferdinandos Skoulidis has studied deeply?
Yes, Ferdinandos Skoulidis has studied treatments such as Carboplatin, Cisplatin, Pemetrexed.
What is the best way to schedule an appointment with Ferdinandos Skoulidis?
Apply for one of the trials that Ferdinandos Skoulidis is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top